27423-79-6 Usage
General Description
2-(3-Fluoro-phenyl)-1H-imidazole is a specific chemical compound with the molecular formula C9H7FN2. It is an imidazole derivative with a fluorine-substituted phenyl group attached to the second carbon atom. 2-(3-FLUORO-PHENYL)-1H-IMIDAZOLE is often used in pharmaceutical research and drug development due to its potential pharmacological properties, including anti-inflammatory and antifungal effects. It has also been studied for its potential use in the treatment of various medical conditions, such as fungal infections and inflammatory diseases. Additionally, it has been investigated for its potential role in modulating neurological function and treating neurological disorders. Overall, 2-(3-Fluoro-phenyl)-1H-imidazole is a compound of interest for its potential therapeutic effects and is the subject of ongoing research in the pharmaceutical and medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 27423-79-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,4,2 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 27423-79:
(7*2)+(6*7)+(5*4)+(4*2)+(3*3)+(2*7)+(1*9)=116
116 % 10 = 6
So 27423-79-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H7FN2/c10-8-3-1-2-7(6-8)9-11-4-5-12-9/h1-6H,(H,11,12)
27423-79-6Relevant articles and documents
MULTIHETEROARYL COMPOUNDS AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES
-
Page/Page column 26, (2010/04/23)
Multiheteroaryl compounds, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical use in the prevention and treatment of prostaglandin D2 mediated diseases and conditions that may be modulated by the inhibition of hematopoietic prostaglandin D synthase (H-PGDS).
Heteroaryl substituted fused bicyclic heteroaryl compound as GABAA receptor ligands
-
, (2008/06/13)
This invention relates to heteroaryl substituted fused bicyclic heteroaryl compounds, such as heteroaryl substituted imidazopyridines, imidazopyrazines, imidazopyridizines, imidazopyrimidines, and imidazothiazoles, which may be described by Formula I or F
